EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Harmonizing amplification and cleavage kinetics through crRNA scaffold mutation enables robust one-pot CRISPR–Cas12 diagnostics

Qingyang Jiang, Ruiquan Xu iD, Zhixin Lin, Chenyu Sun, Feidi Ye, Yanyan Ye iD, Duoming Lin, Zhen Li, Jingwen Mai, Zhihong Lin, Jiuxin Qu, Xiaoyan Deng und 2 weitere

Proceedings of the National Academy of Sciences · 15.09.2026 · 123 (37)

DOI: 10.1073/pnas.2613134123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 09.09.2026. Verfasst von Qingyang Jiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, Guangdong 511436, People's Republic of China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Nucleic Acid Amplification Techniques, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Key National R&D Program of China, the Shenzhen Key Laboratory of Biochip, the Shenzhen Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR-based diagnostics (CRISPR-Dx) integrated with isothermal nucleic acid amplification have emerged as a promising strategy for point-of-care molecular testing. Their practical deployment, however, remains constrained by workflow-related limitations. Conventional two-step formats are laborious and highly susceptible to aerosol contamination during amplicon transfer, whereas simplified one-pot formats often suffer from reduced sensitivity because amplification and CRISPR-mediated cleavage compete kinetically within the same reaction vessel. In this work, we present a broadly applicable one-pot detection strategy termed mutant scaffold-mediated RPA-CRISPR/Cas12a (MS-CRISPR). This approach introduces rationally designed point mutations into the crRNA scaffold to moderately attenuate Cas12a activation and cleavage kinetics. Such kinetic tuning prevents the enzyme from prematurely depleting nascent RPA amplicons, a common source of signal loss in wild-type systems. By delaying cleavage until sufficient amplification products have accumulated, MS-CRISPR markedly enhances endpoint signal output. Using this kinetically balanced system, we achieved a limit of detection of 1 copy/μL for both SARS-CoV-2 and influenza A virus within 15 min, while preserving a fully closed-tube workflow that minimizes aerosol contamination and simplifies operation. We coupled the assay with an instrument-free lateral-flow readout and an ultraportable, multiplex, low-cost microfluidic platform (portable wireless isothermal nucleic acid detection). Clinical validation with patient samples showed 100% sensitivity and specificity for both viral targets. Collectively, MS-CRISPR establishes a sensitive, versatile, and field-deployable platform for rapid pathogen screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNucleic Acid Amplification TechniquesSARS-CoV-2KineticsHumansCRISPR-Associated ProteinsRapid Diagnostic TestsMutationEndodeoxyribonucleasesBacterial Proteins

Stichwörter der Autor:innen

CRISPR/Cas12aRPAmultiplexed nucleic acid testingone-pot detectionscaffold mutation

Substanzen

CRISPR-Associated ProteinsCas12a proteinEndodeoxyribonucleasesBacterial Proteins

Autor:innen und Institutionen

  • KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, Guangdong 511436, People's Republic of China.
  • Guangdong Provincial Engineering Research Center for Early Warning and Diagnosis of Respiratory Infectious Diseases, Guangzhou, Guangdong 511436, People's Republic of China.
  • Department of Clinical Laboratory, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases, Guangdong 5180…
  • College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen 518118, Guangdong, People's Republic of China.

ORCID-Profile: Ruiquan Xu, Yanyan Ye, Dou Wang

Förderung

  • the Key National R&D Program of China
  • the Shenzhen Key Laboratory of Biochip
  • the Shenzhen Science and Technology Program
  • College Students' Innovative Entrepreneurial Training Plan Program
  • College Students’ Innovative Entrepreneurial Training Plan Program

Zitieren

APA

Jiang, Q., Xu, R., Lin, Z., Sun, C., Ye, F., Ye, Y., Lin, D., Li, Z., Mai, J., Lin, Z., Qu, J., Deng, X., Ge, C., & Wang, D. (2026). Harmonizing amplification and cleavage kinetics through crRNA scaffold mutation enables robust one-pot CRISPR–Cas12 diagnostics. Proceedings of the National Academy of Sciences, 123(37). https://doi.org/10.1073/pnas.2613134123

Vancouver

Jiang Q, Xu R, Lin Z, Sun C, Ye F, Ye Y, et al. Harmonizing amplification and cleavage kinetics through crRNA scaffold mutation enables robust one-pot CRISPR–Cas12 diagnostics. Proceedings of the National Academy of Sciences. 2026;123(37). doi:10.1073/pnas.2613134123

BibTeX
@article{Jiang2026,
  author = {Jiang, Qingyang and Xu, Ruiquan and Lin, Zhixin and Sun, Chenyu and Ye, Feidi and Ye, Yanyan and Lin, Duoming and Li, Zhen and Mai, Jingwen and Lin, Zhihong and Qu, Jiuxin and Deng, Xiaoyan and Ge, Chenchen and Wang, Dou},
  title = {Harmonizing amplification and cleavage kinetics through crRNA scaffold mutation enables robust one-pot CRISPR–Cas12 diagnostics},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {37},
  doi = {10.1073/pnas.2613134123}
}
Kostenlos starten →